Royal Fund Management LLC Makes New Investment in SPDR S&P Biotech ETF $XBI

Royal Fund Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 143,713 shares of the exchange traded fund’s stock, valued at approximately $17,536,000. SPDR S&P Biotech ETF makes up about 1.6% of Royal Fund Management LLC’s holdings, making the stock its 10th biggest position. Royal Fund Management LLC owned about 0.20% of SPDR S&P Biotech ETF as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. Compass Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth $1,167,000. China Universal Asset Management Co. Ltd. grew its position in shares of SPDR S&P Biotech ETF by 868.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after purchasing an additional 4,411 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $417,000. Altfest L J & Co. Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 63.1% in the third quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after purchasing an additional 48,326 shares during the last quarter. Finally, Brian Low Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $668,000.

SPDR S&P Biotech ETF Trading Down 0.7%

NYSEARCA:XBI opened at $118.78 on Tuesday. The business’s 50-day moving average is $124.97 and its 200 day moving average is $117.58. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The company has a market capitalization of $7.94 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.